All News
Predictors of severe cranial ischemic complications in Giant cell arteritis. 20%GPC patients presented/developed severe vision manifestations and/or ischemic stroke.. age and jaw claudication predicted severe cranial ischemic complications ~ Alojzija Hocevar #eular2019 https://t.co/PSaRfD5kSa
Dr.Martínez MtzReuma ( View Tweet)
GIACTA update #eular2019
RT @drdavidliew: To recall, part 1 52 wks, TCZ vs placebo & wean prednisolone. By end 52 wks, defined themselves by their response categories: remission no treatment, remission on treatment, active on treatment. What happens when IL-6 inhibition stops?
Dr Irwin Lim _connectedcare ( View Tweet)
IL-17A and IL-17F are secreted by entheseal T cells, and both synergize with TNF to recruit IL-17+ T cells to sites of inflammation. Timely translational data for bimekizumab #EULAR2019 THU0013 from Dennis McGonagle’s Leeds group @RheumNow https://t.co/27DMCBj1VV
David Liew drdavidliew ( View Tweet)
#Comorditiy is common in #gout & distinct #clusters form. #allopurinol can be safely be used in #ckd at higher than historically suggested doses. Uncertainty remains around association between gout & #neurodegeneration. #EULAR2019 @GoutEducation @GoutandYou @PCSciences @elinlowri https://t.co/7z6ZkbnZRZ
Dr James Prior DrJamesPrior ( View Tweet)
Lots of interesting questions posed by Dr. Eckstein #EULAR2019 here’s the FDA draft guidelines on structural endpoints in DMOAd development: https://t.co/mAKpASXXDb https://t.co/xAncVGyZjn
Jamie Collins CollJamie ( View Tweet)
GM-CSF may be implicated in many pathways in GCA, and its genetic signature in fresh temporal arteries is markedly increased in GCA vs controls. The anti-GM-CSF mAbs for GCA - watch this space #EULAR2019 THU0008 by Maria Cid @RheumNow https://t.co/smStOBq17b
David Liew drdavidliew ( View Tweet)
Comorbidity is common in gout, is challenging in CKD, allopurinol can be safely dosed higher than historical, uncertainty about relationships between urate gout and neurodegeneration .. avoid <3mg/dl in long term.. Dr. Roddy UK @KeeleUniversity #EULAR2019 https://t.co/TvESMxHG6y
Dr.Martínez MtzReuma ( View Tweet)
We’re starting to get a better idea of rheumatic irAE phenotypic clusters, which is the first step to better understanding and treatment - onward to collect more data, to get better detail! Many congratulations @ramos_casals! #EULAR2019 THU0649 @RheumNow https://t.co/TBYqb70Hsp
David Liew drdavidliew ( View Tweet)
Updated treatment algorithm for various pathological subtypes of #Lupus Nephritis #EULAR2019 https://t.co/Uun2OQXJLl
Juan Ovalles, MD, PhD DrJuanOvalles ( View Tweet)
In hand OA, both structural and inflammatory features are associated with pain sensitization (PPT = pain pressure threshold) #EULAR2019 OP0417 from Diakonhjemmet in Oslo @RheumNow https://t.co/97GwGGhH6Z
David Liew drdavidliew ( View Tweet)
As we start to use MRI to treat nr-axSpA outside of the tertiary centers, we’ve got to ask - how good are the local readers compared to specialized ones? Caution and more community radiologist education required #EULAR2019 THU0359 from ASAS classification cohort @RheumNow https://t.co/7Qqp1z0chO
David Liew drdavidliew ( View Tweet)
Is GCA seasonality present in the Southern Hemisphere (summer starts in December)? Maybe it’s when our pathologists are feeling summer-generous... small numbers but nice work from @winkler_gemma #EULAR2019 THU0323 @RheumNow https://t.co/v9iT965BAM
David Liew drdavidliew ( View Tweet)
Congratulations to @EricMattesonMD on becoming a honorary member of the EULAR! Well deserved! #EULAR2019 https://t.co/yrjhfS2abB
Elena MyasoedovaMD MyasoedovaElena ( View Tweet)
First day in Numbers 🔢 #EULAR2019
👉🏻 More than 9⃣ million of impressions
👉🏻 Almost 4⃣ thousand Tweets 🐦
👉🏻 From 965 participants #RheumaTwitters
Data from the Healthcare Hashtag Project - Symplur @symplur
🔗
https://t.co/Ib2D1WP09q https://t.co/GIncIijmFs
Juan Ovalles, MD, PhD DrJuanOvalles ( View Tweet)
Interstitial lung disease occurs in about half of all patients with systemic sclerosis; of these, about one-third will experience lung disease progression. "[Patients] needs to be screened [with high resolution CT] because a lung function test is not enough." #EULAR2019
CreakyJoints.org CreakyJoints ( View Tweet)
GiACTA part 2 - the morning has arrived! Disappointment or hope for tocilizumab in GCA? I'll be live tweeting it as we go.
Here's the abstract to start you off:
https://t.co/qtH8E5rVrB
#EULAR2019 OP0140 @RheumNow
David Liew drdavidliew ( View Tweet)
Positive results presented so yes, interest in molecules beyond JAKi. All good for people esp once patents finish! #EULAR2019 https://t.co/beW9GblqdF
Dr Irwin Lim _connectedcare ( View Tweet)
Look at this list of Biosimilars to TNFis! How would you decide what to use? The cost to the payer & what might be imposed? #EULAR2019 https://t.co/DhshdumsXO
Dr Irwin Lim _connectedcare ( View Tweet)
In GCA, concomitant PMR might separate out better prognosis phenotype. Mortality benefit in PMR-relevant OR 0.68 (0.58-0.80). Phenotypes important moving forward in therapeutic selection? #EULAR2019 THU0295 from U La Paz, Madrid @RheumNow https://t.co/4viMygbTcP
David Liew drdavidliew ( View Tweet)
Good morning #EULAR2019 delegates. Come by and visit, meet the Editor! https://t.co/DagNuxGfDq
The Journal of Rheumatology jrheum ( View Tweet)